IL17A and diabetic kidney disease: The anti-inflammatory effect of inhibiting CYP4A/20-HETE in DKD was assessed by measuring MCP-1, IL-1β, IL-6, IL-17, and TNF⍺ in the plasma (Figure 6A) and the kidney cortices (Figure 6B) of the different groups of mice.